JAYPIRCA is Now FDA-Approved for Mantle Cell Lymphoma (MCL) Treatment
For many people living with mantle cell lymphoma (MCL), the standards-of-care include Bruton's tyrosine kinase (BTK) inhibitors. But there is a subset of patients who do not respond well,…